Clinical Trials Browser

Phase 3 × Medroxyprogesterone × Clear all

NCT00026286 2023-06-15

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Phase 3 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast, Hot Flashes

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Phase 3 Completed

BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

NCT00416429 2012-09-26

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms